PTC Therapeutics
PTCT
#3037
Rank
HK$40.38 B
Marketcap
HK$487.85
Share price
-2.97%
Change (1 day)
21.17%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: HK$40.38 Billion

As of March 2026 PTC Therapeutics has a market cap of HK$40.38 Billion. This makes PTC Therapeutics the world's 3037th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$40.38 B-17.72%
2025HK$49.07 B81.21%
2024HK$27.08 B66.73%
2023HK$16.24 B-25.37%
2022HK$21.76 B-0.88%
2021HK$21.95 B-31.99%
2020HK$32.28 B39.35%
2019HK$23.16 B70.34%
2018HK$13.60 B151.54%
2017HK$5.40 B86.23%
2016HK$2.90 B-65.91%
2015HK$8.51 B-35.53%
2014HK$13.21 B321.75%
2013HK$3.13 B

End of Day market cap according to different sources

On Mar 4th, 2026 the market cap of PTC Therapeutics was reported to be:

HK$41.61 Billion
by Nasdaq info icon info icon
HK$41.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
HK$2.413 T 5,876.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$920.71 B 2,180.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$6.30 B-84.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$13.29 B-67.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$1.22 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$87.97 B 117.86%๐Ÿ‡บ๐Ÿ‡ธ USA